about
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesMonoclonal antibody-based therapies for microbial diseasesRecent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal AntibodiesThe isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIVNatural anti-CCR5 antibodies in HIV-infection and -exposureCCR5: From Natural Resistance to a New Anti-HIV Strategy.siRNA-based topical microbicides targeting sexually transmitted infections.Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies.Antibody epitopes on g protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers.Induction of HIV-blocking anti-CCR5 IgA in Peyers's patches without histopathological alterations.Pharmacological modulation of chemokine receptor function.HIV/AIDS: modified stem cells in the spotlight.Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions.The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy.Development of Antibody Therapeutics against Flaviviruses.Antibody-Mediated Therapy against HIV/AIDS: Where Are We Standing Now?
P2860
Q26866236-67506CD8-6A37-40EE-B16A-38477E6B5B30Q27490830-62CFA583-DFD9-4320-A0FE-75EF8E4C32C1Q28068946-699D7FC9-7A27-42FF-B762-B6A8C0B3D2B3Q34939533-F93B4719-B7B3-4423-AE19-06AD8C6B3AFFQ35018133-7E8A0E9C-033A-4BBD-BCE3-DBC58D3C8D15Q35260605-4C0F4663-5DE8-4D9F-8248-B0116A07DCD4Q35766254-2D9E0FA7-FF99-4FE0-9BCF-4ED984A31274Q36602029-EA620683-EC66-4974-B793-6A61F41D0818Q37701720-A0E5FAE8-C2D1-4DB7-8291-A86AF2D14EAEQ37713548-A2E8619A-B17F-447B-924D-807BFE3E7F0AQ37893687-4696085B-B524-4472-8861-A8A69FABD4ABQ38186557-C741DC4B-822B-40CC-8A14-D10C8D887CE3Q41846910-6D668A41-B6FF-432B-915E-75C011E1CBAAQ47107303-C16624CB-0DCC-4260-BDBD-1D397C9C3623Q47174470-6DE5C8E4-778D-4FAD-8F11-C2B17D6A7548Q47558158-E44FF763-2A7E-4D57-BA33-D1ABB64D079AQ55436995-0DDD3797-C531-4111-9849-D710A2436AB7
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CCR5 monoclonal antibodies for HIV-1 therapy
@ast
CCR5 monoclonal antibodies for HIV-1 therapy
@en
CCR5 monoclonal antibodies for HIV-1 therapy
@en-gb
CCR5 monoclonal antibodies for HIV-1 therapy
@nl
type
label
CCR5 monoclonal antibodies for HIV-1 therapy
@ast
CCR5 monoclonal antibodies for HIV-1 therapy
@en
CCR5 monoclonal antibodies for HIV-1 therapy
@en-gb
CCR5 monoclonal antibodies for HIV-1 therapy
@nl
prefLabel
CCR5 monoclonal antibodies for HIV-1 therapy
@ast
CCR5 monoclonal antibodies for HIV-1 therapy
@en
CCR5 monoclonal antibodies for HIV-1 therapy
@en-gb
CCR5 monoclonal antibodies for HIV-1 therapy
@nl
P2860
P3181
P1476
CCR5 monoclonal antibodies for HIV-1 therapy
@en
P2093
Jeffrey M Jacobson
William C Olson
P2860
P304
P3181
P356
10.1097/COH.0B013E3283224015
P407
P577
2009-03-01T00:00:00Z